相似文献
1
Fibroblast Growth Factors in Depression.
Front Pharmacol. 2019 Feb 5;10:60. doi: 10.3389/fphar.2019.00060. eCollection 2019.
2
Fibroblast growth factors and their receptors in the central nervous system.
Cell Tissue Res. 2003 Aug;313(2):139-57. doi: 10.1007/s00441-003-0756-7. Epub 2003 Jul 5.
3
Decreased serum fibroblast growth factor - 2 levels in pre- and post-treatment patients with major depressive disorder.
Neurosci Lett. 2014 Sep 5;579:168-72. doi: 10.1016/j.neulet.2014.07.035. Epub 2014 Jul 29.
4
Epidermal growth factor and fibroblast growth factor-2 circulating levels in elderly with major depressive disorder.
Psychiatry Res. 2019 Feb;272:141-143. doi: 10.1016/j.psychres.2018.12.084. Epub 2018 Dec 18.
5
Fibroblast growth factors in the developing central nervous system.
Clin Exp Pharmacol Physiol. 2001 Jul;28(7):493-503. doi: 10.1046/j.1440-1681.2001.03477.x.
6
Elevated specific peripheral cytokines found in major depressive disorder patients with childhood trauma exposure: a cytokine antibody array analysis.
Compr Psychiatry. 2013 Oct;54(7):953-61. doi: 10.1016/j.comppsych.2013.03.026. Epub 2013 Apr 29.
7
The fibroblast growth factor system and mood disorders.
Biol Psychiatry. 2006 Jun 15;59(12):1128-35. doi: 10.1016/j.biopsych.2006.02.026. Epub 2006 May 2.
8
Alterations in the Levels of Growth Factors in Adolescents with Major Depressive Disorder: A Longitudinal Study during the Treatment with Fluoxetine.
Mediators Inflamm. 2019 Nov 19;2019:9130868. doi: 10.1155/2019/9130868. eCollection 2019.
9
Fibroblast growth factor 9 is a novel modulator of negative affect.
Proc Natl Acad Sci U S A. 2015 Sep 22;112(38):11953-8. doi: 10.1073/pnas.1510456112. Epub 2015 Sep 8.
10
Implications of Fibroblast Growth Factors (FGFs) in Cancer: From Prognostic to Therapeutic Applications.
Curr Drug Targets. 2019;20(8):852-870. doi: 10.2174/1389450120666190112145409.
引用本文的文献
1
Therapeutic potential of calcitriol in cerebral ischemia/reperfusion injury: In vivo and in silico insights into TLR4 and FGFR2 pathways.
IBRO Neurosci Rep. 2025 Jul 29;19:345-353. doi: 10.1016/j.ibneur.2025.06.018. eCollection 2025 Dec.
2
Childhood insulin resistance and neural stem cell dysfunction in psychiatric disorders: Role of lipogenesis and treatment perspectives.
World J Stem Cells. 2025 Jul 26;17(7):106194. doi: 10.4252/wjsc.v17.i7.106194.
3
Relationship Between Obesity and Depression Considering the Inflammatory Theory.
Int J Mol Sci. 2025 May 22;26(11):4966. doi: 10.3390/ijms26114966.
4
Deep learning algorithms reveal genomic markers for anxiety disorder in a large cohort of children with down syndrome.
Mol Psychiatry. 2025 May 24. doi: 10.1038/s41380-025-03065-2.
5
Exploring endocrine FGFs - structures, functions and biomedical applications.
Int J Biochem Mol Biol. 2024 Aug 25;15(4):68-99. doi: 10.62347/PALK2137. eCollection 2024.
6
Precision Medicine in Depression: The Role of Proteomics and Metabolomics in Personalized Treatment Approaches.
Adv Exp Med Biol. 2024;1456:359-378. doi: 10.1007/978-981-97-4402-2_18.
7
Vagus Nerve Stimulation Modulates Inflammation in Treatment-Resistant Depression Patients: A Pilot Study.
Int J Mol Sci. 2024 Feb 26;25(5):2679. doi: 10.3390/ijms25052679.
8
Emergence of Extracellular Vesicles as "Liquid Biopsy" for Neurological Disorders: Boom or Bust.
Pharmacol Rev. 2024 Feb 13;76(2):199-227. doi: 10.1124/pharmrev.122.000788.
9
Bile acid signalling and its role in anxiety disorders.
Front Endocrinol (Lausanne). 2023 Nov 23;14:1268865. doi: 10.3389/fendo.2023.1268865. eCollection 2023.
10
AMEND: active module identification using experimental data and network diffusion.
BMC Bioinformatics. 2023 Jul 6;24(1):277. doi: 10.1186/s12859-023-05376-z.
本文引用的文献
1
Antidepressant-Like Effects of Low- and High-Molecular Weight FGF-2 on Chronic Unpredictable Mild Stress Mice.
Front Mol Neurosci. 2018 Oct 12;11:377. doi: 10.3389/fnmol.2018.00377. eCollection 2018.
2
Fibroblast growth factor 2 is necessary for the antidepressant effects of fluoxetine.
PLoS One. 2018 Oct 1;13(10):e0204980. doi: 10.1371/journal.pone.0204980. eCollection 2018.
3
Fibroblast Growth Factor 2 Modulates Hippocampal Microglia Activation in a Neuroinflammation Induced Model of Depression.
Front Cell Neurosci. 2018 Aug 8;12:255. doi: 10.3389/fncel.2018.00255. eCollection 2018.
4
Basic fibroblast growth factor increased glucocorticoid receptors in cortical neurons through MAP kinase pathway.
Neurochem Int. 2018 Sep;118:217-224. doi: 10.1016/j.neuint.2018.06.009. Epub 2018 Jun 26.
5
Cross-species evidence from human and rat brain transcriptome for growth factor signaling pathway dysregulation in major depression.
Neuropsychopharmacology. 2018 Sep;43(10):2134-2145. doi: 10.1038/s41386-018-0117-6. Epub 2018 Jun 12.
6
FGF Family: From Drug Development to Clinical Application.
Int J Mol Sci. 2018 Jun 26;19(7):1875. doi: 10.3390/ijms19071875.
7
A Genome-Wide Association Study and Complex Network Identify Four Core Hub Genes in Bipolar Disorder.
Int J Mol Sci. 2017 Dec 19;18(12):2763. doi: 10.3390/ijms18122763.
8
Fibroblast growth factor 22 is a novel modulator of depression through interleukin-1β.
CNS Neurosci Ther. 2017 Nov;23(11):907-916. doi: 10.1111/cns.12760. Epub 2017 Sep 25.
9
Effects of central fibroblast growth factor 21 and irisin in anxiety-like behavior.
J Biol Regul Homeost Agents. 2017 Jul-Sep;31(3):797-802.
10
Exogenous FGF2 reverses depressive-like behaviors and restores the suppressed FGF2-ERK1/2 signaling and the impaired hippocampal neurogenesis induced by neuroinflammation.
Brain Behav Immun. 2017 Nov;66:322-331. doi: 10.1016/j.bbi.2017.05.013. Epub 2017 May 18.
Zotero 插件